[1]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109-110114.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(13):109-110114.[doi:10.3969/j.issn.1006-1959.2019.13.032]
点击复制

血液透析联合血液灌流在终末期肾病患者治疗中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年13期
页码:
109-110114
栏目:
临床研究
出版日期:
2019-07-01

文章信息/Info

Title:
Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease
文章编号:
1006-1959（2019）13-0109-03
作者:
魏昌林
成都市双流区第一人民医院肾内科，四川 成都 610000
Author(s):
WEI Chang-lin
Department of Nephrology,the First People's Hospital,Shuangliu District,Chengdu 610000, Sichuan,China
关键词:
血液透析; 血液灌流; 终末期肾病
Keywords:
Key words：Hemodialysis;  Blood perfusion;  End stage renal disease
分类号:
R692.5
DOI:
10.3969/j.issn.1006-1959.2019.13.032
文献标志码:
A
摘要:
目的 探究血液透析联合血液灌流在终末期肾病患者治疗中的应用效果。方法 选取我院2016年1月~2018年12月治疗的终末期肾病患者94例，其中47例接受血液透析治疗，为对照组；另外47例接受血液透析联合血液灌流治疗，为试验组。比较两组治疗前后的血清β2微球蛋白（β2-MG）、甲状旁腺激素（PTH）、血肌酐（Scr）、尿素氮（BUN）和临床疗效。结果 试验组β2-MG、PTH、Scr和BUN水平分别为（2.94±0.52）mg/L、（251.64±20.42）pg/L、（532.69±114.31）μmol/L和（10.58±2.68）mmol/L，均低于对照组的［（4.89±0.64）mg/L、（270.83±22.45）pg/L、（580.25±118.57）μmol/L和（13.44±3.59）mmol/L］，差异有统计学意义（P＜0.05）。试验组治疗总有效率高于对照组（93.62% vs 78.72%），差异有统计学意义（P＜0.05）。结论 对终末期肾病患者采用血液透析联合血液灌流治疗，有利于改善患者的各项生理指标，提高临床疗效。
Abstract:
Abstract：Objective To explore the effect of hemodialysis combined with blood perfusion in the treatment of patients with end-stage renal disease. Methods A total of 94 patients with end-stage renal disease treated in our hospital from January 2016 to December 2018 were enrolled. Among them, 47 patients underwent hemodialysis treatment as the control group. Another 47 patients underwent hemodialysis combined with hemoperfusion as the test group. Serum β2 microglobulin (β2-MG), parathyroid hormone (PTH), serum creatinine (Scr), urea nitrogen (BUN) and clinical efficacy were compared before and after treatment. Results The levels of β2-MG, PTH, Scr and BUN in the test group were (2.94±0.52) mg/L, (251.64±20.42) pg/L, (532.69±114.31) μmol/L and (10.58±2.68) mmol/L, respectively,were lower than the control group (4.89±0.64) mg/L, (270.83±22.45) pg/L, (580.25±118.57) μmol/L and (13.44±3.59) mmol/L], the difference was statistically significant (P<0.05). The total effective rate of the test group was higher than that of the control group (93.62% vs 78.72%),the difference was statistically significant (P<0.05). Conclusion Hemodialysis combined with hemoperfusion in patients with end-stage renal disease is beneficial to improve various physiological indicators and improve clinical efficacy.

参考文献/References:

[1]王志强,李瑞英.高通量血液透析联合血液灌流治疗老年慢性肾衰竭的效果分析[J].中国继续医学教育,2017,9(21):120-121. [2]Krolewski AS,Skupien J,Rossing P,et al.Fast renal decline to end-stagerenal disease:an unrecognized feature of nephropathy in diabetes[J].Kidney Int,2017,91(6):1300-1311. [3]赵玉钰.血液灌流联合血液透析治疗急性肾衰竭的临床分析[J].中国医疗器械信息,2018,24(24):92-93. [4]王芬.血液灌流联合血液透析在重度急性中毒中的救治体会[J].现代医用影像学,2018,27(8):2947-2948. [5]冀旭,孟宇,薛泮宏.血液透析联合血液灌流对终末期肾病患者ApoC3、血脂代谢及心脏结构与功能的影响[J].内科急危重症杂志,2017,23(3):233-236. [6]雷磊.高通量血液透析联合血液灌流对终末期肾病患者中大分子溶质清除效果的影响[J].医药论坛杂志,2018,39(2):99-101. [7]刘汉伟,张振辉,唐纪文,等. HD+HP对老年终末期肾病动脉粥样硬化及心血管并发症的预防效果[J].河北医科大学学报,2017,38(8):886-890. [8]贾军利,王淑萍,李迎婕,等.血液透析联合血液灌流对维持性血液透析患者微炎症状态及骨代谢影响[J].临床军医杂志,2017,45(12):1282-1284. [9]王友彬.血液灌流联合血液透析治疗尿毒症疗效及对患者肾功能的影响[J].临床医药文献杂志,2017,4(44):80.

相似文献/References:

[1]李伟东,单 静,曹 翔,等.血液灌流联合血液滤过在重症胰腺炎患者中的疗效及预后影响研究[J].医学信息,2018,31(03):103.[doi:10.3969/j.issn.1006-1959.2018.03.033]
　LI Wei-dong,SHAN Jing,CAO Xiang,et al.Study on Curative Effect and Prognosis of Hemoperfusion Combined with Hemofiltration in Patients with Severe Pancreatitis[J].Journal of Medical Information,2018,31(13):103.[doi:10.3969/j.issn.1006-1959.2018.03.033]
[2]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Journal of Medical Information,2018,31(13):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[3]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Journal of Medical Information,2018,31(13):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[4]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Journal of Medical Information,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[5]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Journal of Medical Information,2019,32(13):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[6]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Journal of Medical Information,2018,31(13):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[7]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Journal of Medical Information,2019,32(13):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[8]李钦涛.不同剂量肝素在血液灌流治疗农药中毒中的应用[J].医学信息,2019,32(20):110.[doi:10.3969/j.issn.1006-1959.2019.19.032]
　LI Qin-tao.Application of Different Doses of Heparin in the Treatment of Pesticide Poisoning by Blood Perfusion[J].Journal of Medical Information,2019,32(13):110.[doi:10.3969/j.issn.1006-1959.2019.19.032]
[9]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(13):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[10]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
　WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Journal of Medical Information,2022,35(13):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
[11]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Journal of Medical Information,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[12]钟瑜辉.血液透析联合血液灌流治疗尿毒症的效果[J].医学信息,2019,32(21):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
　ZHONG Yu-hui.Effect of Hemodialysis Combined with Blood Perfusion on Uremia[J].Journal of Medical Information,2019,32(13):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
[13]唐 建,朱倩莹,刘 莉,等.血液透析联合血液灌流治疗尿毒症皮肤瘙痒症的疗效[J].医学信息,2020,33(01):118.[doi:10.3969/j.issn.1006-1959.2020.01.036]
　TANG Jian,ZHU Qian-ying,LIU Li,et al.Hemodialysis Combined with Hemoperfusion in the Treatment of Uremia and Skin Pruritus[J].Journal of Medical Information,2020,33(13):118.[doi:10.3969/j.issn.1006-1959.2020.01.036]
[14]孟凡丽.血液透析联合血液灌流对慢性肾衰竭患者血清炎性因子及免疫功能的影响[J].医学信息,2022,35(19):57.[doi:10.3969/j.issn.1006-1959.2022.19.015]
　MENG Fan-li.Effect of Hemodialysis Combined with Hemoperfusion on Serum Inflammatory Factors and Immune Function in Patients with Chronic Renal Failure[J].Journal of Medical Information,2022,35(13):57.[doi:10.3969/j.issn.1006-1959.2022.19.015]

更新日期/Last Update: 2019-07-01